Joanne Wang

This inventor holds 26 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Immunoassays. Top assignees: Allergan, Inc., Other. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joanne Wang. Retrieved from https://idiyas.com/inventor/joanne-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 15)

% Patents Active = 84.6

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 159(Granted Patents)

Company Filing History:

25 out of 2,287

Allergan, Inc.

patents

1 out of 834,513

Other

patents

Years Active: 2012-2022

Loading Chart...

Areas of Expertise:

Immunoassays

Botulinum Toxin

Neurotoxin Detection

Endopeptidase Activity

Serotype A

Cell-Based Assays

Melanocyte Disorders

Activity Assays

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11332518 - Immuno-based botulinum toxin serotype A activity assays (2022-05-17),

2. 11261240 - Immuno-based botulinum toxin serotype A activity assays (2022-03-01),

3. 10912823 - Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin (2021-02-09),

4. 10900967 - Immuno-based retargeted endopeptidase activity assays (2021-01-26),

5. 10703806 - Immuno-based botulinum toxin serotype A activity assays (2020-07-07),

6. 10451621 - Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A (2019-10-22),

7. 10345306 - Immuno-based retargeted endopeptidase activity assays (2019-07-09),

8. 9651553 - Immuno-based retargeted endopeptidase activity assays (2017-05-16),

9. 9625447 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2017-04-18),

10. 9249216 - Immuno-based botulinum toxin serotype A activity assays (2016-02-02),

11. 8691566 - Cells useful for immuno-based botulinum toxin serotype a activity assays (2014-04-08),

12. 8663983 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2014-03-04),

13. 8663982 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2014-03-04),

14. 8618261 - Immuno-based botulinum toxin serotype A activity assays (2013-12-31),

15. 8603813 - Cells useful for immuno-based botulinum toxin serotype A activity assays (2013-12-10),

Title: The Innovative Journey of Joanne Wang

Introduction: Joanne Wang, a pioneering inventor based in Irvine, CA, has made significant contributions to the world of technology and innovation. Her passion for creating groundbreaking solutions has led to numerous patents and collaborations in various industries.

Latest Patents: Joanne Wang's latest patents focus on advancements in renewable energy technologies, specifically in the development of solar-powered devices for sustainable living. Her innovative designs have garnered attention for their efficiency and eco-friendly features.

Career Highlights: With a background in engineering and a keen eye for detail, Joanne Wang has established herself as a leading figure in the field of clean energy solutions. Her career highlights include receiving prestigious awards for her contributions to the renewable energy sector and being recognized as a thought leader in the industry.

Collaborations: Joanne Wang has collaborated with top research institutions and leading companies to further her innovative projects. Her partnerships have resulted in groundbreaking technologies that have the potential to revolutionize the way we harness and utilize renewable energy sources.

Conclusion: Joanne Wang's dedication to innovation and sustainability continues to inspire the next generation of inventors. Her relentless pursuit of excellence and commitment to creating a greener future make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.